This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Eisai Co. Ltd. bought the European marketing rights to Elan Corp. PLC's pain medicine Prialt (ziconotide) for $50mm up front plus $10mm at the earlier of two years or the drug's launch in key European markets.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?